檢索結果 - Isabelle Ray‐Coquard

Refine Results
  1. 1
    Soft Tissue and Uterine Leiomyosarcoma

    Soft Tissue and Uterine Leiomyosarcoma 由 Suzanne George, César Serrano, Martee L. Hensley, Isabelle Ray‐Coquard

    出版 2017
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Challenges for immunotherapy for the treatment of platinum resistant ovarian cancer

    Challenges for immunotherapy for the treatment of platinum resistant ovarian cancer 由 Olivia Le Saux, Isabelle Ray‐Coquard, Sana Intidhar Labidi‐Galy

    出版 2020
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?

    Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines? 由 Christine Ménétrier‐Caux, Isabelle Ray‐Coquard, Jean‐Yves Blay, Christophe Caux

    出版 2019
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Emerging treatment strategies in recurrent platinum-sensitive ovarian cancer: Focus on trabectedin

    Emerging treatment strategies in recurrent platinum-sensitive ovarian cancer: Focus on trabectedin 由 Andrés Poveda, Isabelle Ray‐Coquard, Ignacio Romero, José Antonio López‐Guerrero, Nicoletta Colombo

    出版 2013
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT)

    Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT) 由 Jean‐Yves Blay, Hiba El Sayadi, P. Thiesse, Jérôme Garret, Isabelle Ray‐Coquard

    出版 2008
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  6. 6
    Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials

    Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials 由 Andreas du Bois, Alexander Reuß, Eric Pujade‐Lauraine, Philipp Harter, Isabelle Ray‐Coquard, Jacobus Pfisterer

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients

    Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients 由 Thomas Bachelot, Isabelle Ray‐Coquard, Christine Ménétrier‐Caux, M Rastkha, Adeline Duc, Jean‐Yves Blay

    出版 2003
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Potential Role of Lymphadenectomy in Advanced Ovarian Cancer: A Combined Exploratory Analysis of Three Prospectively Randomized Phase III Multicenter Trials

    Potential Role of Lymphadenectomy in Advanced Ovarian Cancer: A Combined Exploratory Analysis of Three Prospectively Randomized Phase III Multicenter Trials 由 Andreas du Bois, Alexander Reuß, Philipp Harter, Éric Pujade-Lauraine, Isabelle Ray‐Coquard, Jacobus Pfisterer

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Novel Therapeutic Options for Solitary Fibrous Tumor: Antiangiogenic Therapy and Beyond

    Novel Therapeutic Options for Solitary Fibrous Tumor: Antiangiogenic Therapy and Beyond 由 Axel de Bernardi, Armelle Dufresne, Florence Mishellany, Jean‐Yves Blay, Isabelle Ray‐Coquard, Mehdi Brahmi

    出版 2022
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  10. 10
    Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 由 Isabelle Ray‐Coquard, Philippe Morice, Domenica Lorusso, Jaime Prat, Ana Oaknin, Patricia Pautier, Nicoletta Colombo

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Adjuvant therapy with imatinib in gastrointestinal stromal tumors (GISTs)—review and perspectives

    Adjuvant therapy with imatinib in gastrointestinal stromal tumors (GISTs)—review and perspectives 由 Marie Laurent, Mehdi Brahmi, Armelle Dufresne, Pierre Méeus, Marie Karanian, Isabelle Ray‐Coquard, Jean‐Yves Blay

    出版 2019
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  12. 12
    Recurrent or primary metastatic cervical cancer: current and future treatments

    Recurrent or primary metastatic cervical cancer: current and future treatments 由 Christine Gennigens, Guy Jérusalem, L. Lapaille, Marjolein De Cuypere, Sylvie Streel, Frédéric Kridelka, Isabelle Ray‐Coquard

    出版 2022
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  13. 13
    BRCA1/2 alterations and reversion mutations in the area of PARP inhibitors in high grade ovarian cancer: state of the art and forthcoming challenges

    BRCA1/2 alterations and reversion mutations in the area of PARP inhibitors in high grade ovarian cancer: state of the art and forthcoming challenges 由 L. Collet, Brunhilde Hanvic, Margherita Turinetto, Isabelle Treilleux, Nicolás Chopin, Olivia Le Saux, Isabelle Ray‐Coquard

    出版 2024
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  14. 14
    Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience

    Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience 由 Alice Levard, Olfa Derbel, Pierre Méeus, Dominique Ranchère, Isabelle Ray‐Coquard, Jean‐Yves Blay, Philippe A. Cassier

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion

    First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion 由 Susana Banerjee, Antonio González‐Martín, Philipp Harter, Domenica Lorusso, Kathleen N. Moore, Ana Oaknin, Isabelle Ray‐Coquard

    出版 2020
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  16. 16
    PARP-inhibitors in epithelial ovarian cancer: Actual positioning and future expectations

    PARP-inhibitors in epithelial ovarian cancer: Actual positioning and future expectations 由 Hélène Vanacker, Philipp Harter, Sana Intidhar Labidi‐Galy, Susana Banerjee, Ana Oaknin, Domenica Lorusso, Isabelle Ray‐Coquard

    出版 2021
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  17. 17
    Endometrial cancer

    Endometrial cancer 由 Vicky Makker, Helen Mackay, Isabelle Ray‐Coquard, Douglas A. Levine, Shannon N. Westin, Daisuke Aoki, Ana Oaknin

    出版 2021
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  18. 18
    Beyond the map: evidencing the spatial dimension of health inequalities

    Beyond the map: evidencing the spatial dimension of health inequalities 由 Yohan, Fayet, Delphine, Praud, Béatrice, Fervers, Isabelle, Ray-Coquard, Jean-Yves, Blay, Françoise, Ducimetiere, Guy, Fagherazzi, Elodie, Faure

    出版 2020
    獲取全文 獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:
  19. 19
    The forefront of ovarian cancer therapy: update on PARP inhibitors

    The forefront of ovarian cancer therapy: update on PARP inhibitors 由 Mansoor Raza Mirza, Robert L. Coleman, Antonio González-Martı́n, Kathleen N. Moore, Nicoletta Colombo, Isabelle Ray‐Coquard, Sandro Pignata

    出版 2020
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  20. 20
    Ovarian clear cell carcinoma: open questions on the management and treatment algorithm

    Ovarian clear cell carcinoma: open questions on the management and treatment algorithm 由 Roberta Rosso, Margherita Turinetto, Fulvio Borella, Nicolás Chopin, Pierre Méeus, Andrew F. Laine, Isabelle Ray‐Coquard, Olivia Le Saux, Domenico Ferraioli

    出版 2025
    獲取全文
    Revisão
    加到收藏夾
    Saved in:

檢索工具: